The Pcsk9DY mutation (encoding the Asp374-to-Tyr mutant) induces the degradation of hepatic low-density lipoprotein receptors (LDLR) in hepatocytes, closely mimicking the phenotype observed in LDLR−/− mice and effectively induces hyperlipidemia.18 The gene discussed is VLDLR; the disease is hyperlipidemia.